Morgan Rettig is an associate in the Washington, D.C. office of Latham & Watkins and a member of the Healthcare & Life Sciences Practice. Ms. Rettig’s practice focuses on regulatory matters involving the pharmaceutical, medical device, cosmetic, tobacco and biotechnology industries. Ms. Rettig has advised clients on a broad range of regulatory matters involving the US Food and Drug Administration (FDA), including, among others: pre-market product development and submissions; administrative appeals; non-patent exclusivity, including orphan products; product promotion and labeling; and controlled substances compliance.
Ms. Rettig also has experience advising life sciences and healthcare clients on litigation matters, including administrative law challenges and contract disputes. She has participated in developing litigation strategy, drafting dispositive and non-dispositive motions, and reviewing settlement agreements. In the transactional area, Ms. Rettig provides regulatory counsel on capital markets transactions as well as mergers and acquisitions. She has also reviewed several types of agreements for healthcare clients, including manufacturing and supply, licensing and consulting agreements.
Prior to joining Latham, Ms. Rettig clerked for Judge Amy Berman Jackson of the United States District Court for the District of Columbia. Ms. Rettig earned her Juris Doctor degree from Stanford Law School, and holds a Bachelor of Arts degree in Ecology and Evolutionary Biology from Princeton University.